Literature DB >> 22464814

Does complement play a role in bone development and regeneration?

Philipp Schoengraf1, John D Lambris, Stefan Recknagel, Ludwika Kreja, Astrid Liedert, Rolf E Brenner, Markus Huber-Lang, Anita Ignatius.   

Abstract

The skeletal and the immune system are not two independent systems, rather, there are multifaceted and complex interactions between the different cell types of both systems and there are several shared cytokines. As a part of the innate immunity, the complement system was found to be an important link between bone and immunity. Complement proteins appear to be involved in bone development and homeostasis, and specifically influence osteoblast and osteoclast activity. This review describes the complex mutual regulation of the two systems, and indicates some of the negative side effects as a result of inappropriate or excessive complement activation.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22464814     DOI: 10.1016/j.imbio.2012.01.020

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  29 in total

Review 1.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

2.  Identification of Hip BMD Loss and Fracture Risk Markers Through Population-Based Serum Proteomics.

Authors:  Carrie M Nielson; Jack Wiedrick; Jian Shen; Jon Jacobs; Erin S Baker; Aaron Baraff; Paul Piehowski; Christine G Lee; Arie Baratt; Vladislav Petyuk; Shannon McWeeney; Jeong Youn Lim; Douglas C Bauer; Nancy E Lane; Peggy M Cawthon; Richard D Smith; Jodi Lapidus; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2017-04-06       Impact factor: 6.741

Review 3.  Bone and the innate immune system.

Authors:  Julia F Charles; Mary C Nakamura
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

4.  Sex dimorphic regulation of osteoprogenitor progesterone in bone stromal cells.

Authors:  Alexander Kot; Zhendong A Zhong; Hongliang Zhang; Yu-An Evan Lay; Nancy E Lane; Wei Yao
Journal:  J Mol Endocrinol       Date:  2017-09-04       Impact factor: 5.098

5.  Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.

Authors:  Daniel Ajona; Carolina Zandueta; Leticia Corrales; Haritz Moreno; María J Pajares; Sergio Ortiz-Espinosa; Elena Martínez-Terroba; Naiara Perurena; Fernando J de Miguel; Eloisa Jantus-Lewintre; Carlos Camps; Silvestre Vicent; Jackeline Agorreta; Luis M Montuenga; Ruben Pio; Fernando Lecanda
Journal:  Am J Respir Crit Care Med       Date:  2018-05-01       Impact factor: 21.405

6.  Characterization of the chondrocyte secretome in photoclickable poly(ethylene glycol) hydrogels.

Authors:  Margaret C Schneider; Christopher A Barnes; Stephanie J Bryant
Journal:  Biotechnol Bioeng       Date:  2017-05-12       Impact factor: 4.530

7.  Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction.

Authors:  Marcin Wysoczynski; Mitesh Solanki; Sylwia Borkowska; Patrick van Hoose; Kenneth R Brittian; Sumanth D Prabhu; Mariusz Z Ratajczak; Gregg Rokosh
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

8.  Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.

Authors:  Parnian Kalbasi Anaraki; Margret Patecki; Jan Larmann; Sergey Tkachuk; Kerstin Jurk; Hermann Haller; Gregor Theilmeier; Inna Dumler
Journal:  Stem Cells Dev       Date:  2013-12-11       Impact factor: 3.272

Review 9.  Complement-triggered pathways orchestrate regenerative responses throughout phylogenesis.

Authors:  Dimitrios C Mastellos; Robert A Deangelis; John D Lambris
Journal:  Semin Immunol       Date:  2013-05-17       Impact factor: 11.130

10.  IL-1β inhibits human osteoblast migration.

Authors:  Nina-Emily Hengartner; Jörg Fiedler; Anita Ignatius; Rolf E Brenner
Journal:  Mol Med       Date:  2013-04-30       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.